Clinical trial
Phase 1 meCS6 + LT(R192G) Vaccine Study
NCT00090688 · U.S. Army Medical Research and Development Command, U.S. Fed · Withdrawn
Key facts
| NCT number | NCT00090688 |
|---|---|
| Title | Phase 1 meCS6 + LT(R192G) Vaccine Study |
| Official title | Safety and Immunogenicity of Oral Microencapsulated CS6 Vaccine and LT(R192G) Adjuvant in Volunteers |
| Lead sponsor | U.S. Army Medical Research and Development Command, U.S. Fed |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diarrhea |
| Intervention type | Biological |
| Interventions | meCS6 + LT(R192G) |
| Enrollment | 0 |
| Start date | Aug 1, 2004 |
| First posted | Sep 3, 2004 |
| Last update posted | Dec 28, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: